δ9-THC-d9 (CRM) (Synonyms: Δ9-Tetrahydrocannabinol-d9, Dronabinol-d9) |
カタログ番号GC49579 |
認定基準物質
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
δ9-THC-d9 (CRM) is intended for use as an internal standard for the quantification of δ9-THC-d9 by GC- or LC-MS. δ9-THC-d9 is categorized as a cannabinoid.1,2 It is psychoactive and has diverse effects on perception, cognition, and pain sensitivity.3 δ9-THC-d9 is regulated as a Schedule I compound in the United States. δ9-THC-d9 (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
1.Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al.1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptorsBioorg. Med. Chem. Lett.16(20)5432-5435(2006) 2.Pertwee, R.G.Pharmacology of cannabinoid receptor ligandsCurr. Med. Chem.6(8)635-664(1999) 3.Grotenhermen, F.Pharmacokinetics and pharmacodynamics of cannabinoidsClin. Pharmacokinet.42(4)327-360(2003)
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *